Newsroom

Categories: Corporate, Finance & Investor, Clinical Diagnostics

Medix Biochemica appoints Petra Furu as Chief Executive Officer

April 15, 2026

Categories: Clinical Research & Trials, Clinical Diagnostics

CellCarta and Pillar Biosciences announce multi-year global strategic partnership to expand rapid, decentralized tumor profiling for oncology clinical trials

April 2, 2026

Categories: Biotechnology, Corporate, Finance & Investor, Clinical Diagnostics

EazeBio and UC Santa Cruz announce strategic partnership to advance instrument-free diagnostic platform

October 29, 2025

Categories: Biotechnology, Drug Discovery & Development, Pharma, Clinical Diagnostics

Aptamer Group introduces novel biomarker discovery service

August 28, 2025

Categories: Pharma, Corporate, Finance & Investor, Clinical Diagnostics

Medix Biochemica expands its offering of critical IVD raw materials to premium blockers and stabilizers by acquiring CANDOR Bioscience

January 22, 2025

Categories: Healthcare, Corporate, Finance & Investor, Clinical Diagnostics

PrecisionLife appoints Bill Keating as Chief Commercial Officer, Diagnostics and Healthcare

January 8, 2025

Categories: Healthcare, Computing & Technology, Drug Discovery & Development, Corporate, Finance & Investor, Clinical Diagnostics

Leica Biosystems and Indica Labs announce significant strategic investment and creation of digital pathology platform

January 8, 2025

Categories: Microscopy & Imaging, Clinical Diagnostics

The Institute of Tissue Medicine of the University of Bern chooses Indica Labs’ HALO AP®

December 11, 2024

Categories: Corporate, Finance & Investor, Clinical Diagnostics

DevCo has completed a strategic capital raise for its long-term investment in Medix Biochemica

September 16, 2024